Cargando…

Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro

BACKGROUND: Gleevec (aka STI571, Imatinib) is a recently FDA approved anti-tumor drug for chronic myelogenous leukemia. Gleevec binds specifically to BCR-ABL tyrosine kinase and inhibit the tyrosine kinase activity. It cross-reacts with another two important membrane tyrosine kinase receptors, c-kit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peilin, Gao, Wei Yi, Turner, Steven, Ducatman, Barbara S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149413/ https://www.ncbi.nlm.nih.gov/pubmed/12537587 http://dx.doi.org/10.1186/1476-4598-2-1

Ejemplares similares

Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003)

Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571)
por: Pinder, Elizabeth M., et al.
Publicado: (2007)

Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease
por: Re, D, et al.
Publicado: (2002)

Management of Skin Toxicity Related to the Use of Imatinib Mesylate (STI571, Glivec™) for Advanced Stage Gastrointestinal Stromal Tumours
por: Scott, Lucy C., et al.
Publicado: (2005)

Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome‐wide cDNA Microarray Analysis
por: Kaneta, Yasuyuki, et al.
Publicado: (2002)

The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR–ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
por: Liu, W M, et al.
Publicado: (2002)

Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles
por: Lin, You-Zhe, et al.
Publicado: (2021)

Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo
por: LIU, DEZHI, et al.
Publicado: (2014)

Energetic dissection of Gleevec’s selectivity towards human tyrosine kinases
por: Agafonov, R.V., et al.
Publicado: (2014)

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines
por: Uziel, O, et al.
Publicado: (2005)

Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation
por: Deutsch, E, et al.
Publicado: (2004)

Effects of Imatinib Mesylate (Gleevec) on Human Islet NF-kappaB Activation and Chemokine Production In Vitro
por: Mokhtari, Dariush, et al.
Publicado: (2011)

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008)

Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells
por: Pan, Jingxuan
Publicado: (2012)

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
por: Cho, Ah Young, et al.
Publicado: (2011)

Subcapsular Liver Hematoma in Metastatic GIST Complicating Imatinib (Gleevec) Therapy
por: Shankar, Sridhar
Publicado: (2015)

A combination of STI571 and BCR-ABL1 siRNA with overexpressed p15INK4B induced enhanced proliferation inhibition and apoptosis in chronic myeloid leukemia
por: Xia, D.Y., et al.
Publicado: (2014)

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia
por: O'Brien, S G, et al.
Publicado: (2003)

STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death
por: Huang, Duen-Yi, et al.
Publicado: (2012)

Gleevec, an Abl Family Inhibitor, Produces a Profound Change in Cell Shape and Migration
por: Chen, Zaozao, et al.
Publicado: (2013)

Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin
por: Xiao, Xia, et al.
Publicado: (2014)

Computational Study of Gleevec and G6G Reveals Molecular Determinants of Kinase Inhibitor Selectivity
por: Lin, Yen-Lin, et al.
Publicado: (2014)

Copper Mediates Anti-Inflammatory and Antifibrotic Activity of Gleevec in Hepatocellular Carcinoma-Induced Male Rats
por: Hassan, Iftekhar, et al.
Publicado: (2019)

Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma
por: Somlyai, Gábor, et al.
Publicado: (2017)

NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells
por: Du, Aolin, et al.
Publicado: (2018)

571 Clinical and Laboratory Studies of the Fate of Intranasal Allergen
por: Rimmer, Janet, et al.
Publicado: (2012)

Perforation of the Colon During Imatinib Mesylate (Gleevec) Treatment in a Patient with Chronic Myeloid Leukemia (CML)
por: El Jurdi, Najla, et al.
Publicado: (2016)

Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
por: Gao, Zhao-jia, et al.
Publicado: (2018)

Synergistic Antitumor Effect of Oligogalacturonides and Cisplatin on Human Lung Cancer A549 Cells
por: Huang, Cian-Song, et al.
Publicado: (2018)

PRDM14 mediates chemosensitivity and glycolysis in drug-resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells
por: He, Saifei, et al.
Publicado: (2021)

The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017)

Acute Treatment With Gleevec Does Not Promote Early Vascular Recovery Following Intracerebral Hemorrhage in Adult Male Rats
por: Abbas, Mohammed, et al.
Publicado: (2020)

Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro
por: Liu, Yanguo, et al.
Publicado: (2021)

Reversal of multidrug resistance by cisplatin-loaded magnetic Fe(3)O(4) nanoparticles in A549/DDP lung cancer cells in vitro and in vivo
por: Li, Ke, et al.
Publicado: (2013)

The genome of the versatile nitrogen fixer Azorhizobium caulinodans ORS571
por: Lee, Kyung-Bum, et al.
Publicado: (2008)

SUN-571 Thymic Hyperplasia: An Unusual Manifestation of Graves’ Disease
por: Agarwal, Priyanka, et al.
Publicado: (2019)

SAT-571 Rare Case of Tocilizumab-Induced Severe Hypertriglyceridemia
por: Modi, Ankur, et al.
Publicado: (2020)

FRI571 Maternal Graves’ Disease With Foetal Thyrotoxicosis And Goitre
por: Fennell, David, et al.
Publicado: (2023)

Myricanol 5-fluorobenzyloxy ether regulation of survivin pathway inhibits human lung adenocarcinoma A549 cells growth in vitro
por: Dai, Guan-hai, et al.
Publicado: (2020)

α-Hederin inhibits the growth of lung cancer A549 cells in vitro and in vivo by decreasing SIRT6 dependent glycolysis
por: Fang, Cong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_amgpu4on52fmnujn0i941sjaji